Literature DB >> 35015103

Impedance planimetry (EndoFLIP™) reveals changes in gastroesophageal junction compliance during fundoplication.

Hoover Wu1,2, Mikhail Attaar3,4, Harry J Wong3,4, Michelle Campbell3,4, Kristine Kuchta5, Woody Denham3, John Linn3, Michael B Ujiki3.   

Abstract

INTRODUCTION: Compliance is the ability of a hollow organ to dilate and increase volume with an increase in pressure, an accurate representation of food bolus transit through the gastroesophageal junction (GEJ). Impedance planimetry system can calculate compliance (change in volume over pressure) and distensibility (cross-sectional area over pressure) of the GEJ. We aim to describe the changes in compliance during anti-reflux surgery and hypothesize that compliance is a better predictor of patient outcomes than distensibility (DI). METHODS AND PROCEDURES: A review of a prospectively maintained quality database was performed. Patients with FLIP measurements during laparoscopic fundoplication between August 2018 and June 2021 were included. GEJ compliance and DI were measured after hernia reduction, cruroplasty, and fundoplication. Patient-reported outcomes were collected through standardized surveys up to 2 years after surgery. A scatter plot was used to identify a correlation between compliance and DI. Comparisons of measurements between time points were made using paired t-tests. Spearman's correlation coefficients (ρ), Wilcoxon rank-sum, and chi-square tests were used to evaluate associations between measurements and outcomes.
RESULTS: One hundred and forty-four patients underwent laparoscopic fundoplication. Compliance is strongly associated with DI (r = 0.96), and a comparison of measurements showed similar trends at specific time points during the operation. After hernia reduction, compliance at the GEJ was 168 ± 74 mm3/mmHg, cruroplasty 79 ± 39 mm3/mmHg, and fundoplication 90 ± 33 mm3/mmHg (all comparisons p < 0.05). GEJ compliance of 80-92 mm3/mmHg after fundoplication was associated with the best patient-reported outcome scores. A compliance of ≤ 79 mm3/mmHg had the highest percentage of patients who reported dysphagia.
CONCLUSIONS: Compliance and DI are strongly associated displaying the same directional change during anti-reflux surgery. GEJ compliance of 80-92 mm3/mmHg revealed the best patient-reported outcome scores, and avoiding a compliance ≤ 79 mm3/mmHg may prevent postoperative dysphagia. Therefore, GEJ compliance is an underutilized FLIP measurement warranting further investigation.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  EndoFLIP; Fundoplication; GERD; Impedance planimetry; Outcomes

Mesh:

Year:  2022        PMID: 35015103     DOI: 10.1007/s00464-021-08966-1

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   3.453


  14 in total

Review 1.  Effectiveness of laparoscopic fundoplication in relieving the symptoms of gastroesophageal reflux disease (GERD) and eliminating antireflux medical therapy.

Authors:  P K Papasavas; R J Keenan; W W Yeaney; P F Caushaj; D J Gagné; R J Landreneau
Journal:  Surg Endosc       Date:  2003-05-13       Impact factor: 4.584

2.  Is that 'floppy' fundoplication tight enough?

Authors:  Brexton Turner; Melissa Helm; Emily Hetzel; Jon C Gould
Journal:  Surg Endosc       Date:  2019-07-08       Impact factor: 4.584

3.  Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP).

Authors:  Monika A Kwiatek; John E Pandolfino; Ikuo Hirano; Peter J Kahrilas
Journal:  Gastrointest Endosc       Date:  2010-06-11       Impact factor: 9.427

4.  Using impedance planimetry (EndoFLIP™) in the operating room to assess gastroesophageal junction distensibility and predict patient outcomes following fundoplication.

Authors:  Bailey Su; Stephanie Novak; Zachary M Callahan; Kristine Kuchta; JoAnn Carbray; Michael B Ujiki
Journal:  Surg Endosc       Date:  2019-06-19       Impact factor: 4.584

5.  Anti-reflux mucosectomy (ARMS) results in improved recovery and similar reflux quality of life outcomes compared to laparoscopic Nissen fundoplication.

Authors:  Harry J Wong; Bailey Su; Mikhail Attaar; Kristine Kuchta; Stephen Stearns; John G Linn; Stephen P Haggerty; Woody Denham; Michael B Ujiki
Journal:  Surg Endosc       Date:  2020-11-25       Impact factor: 4.584

6.  Esophagogastric junction distensibility after fundoplication assessed with a novel functional luminal imaging probe.

Authors:  Monika A Kwiatek; Kahrilas Kahrilas; Nathaniel J Soper; William J Bulsiewicz; Barry P McMahon; Hans Gregersen; John E Pandolfino
Journal:  J Gastrointest Surg       Date:  2010-02       Impact factor: 3.452

7.  Use of Impedance Planimetry (Endoflip) in Foregut Surgery Practice: Experience of More than 400 Cases.

Authors:  Bailey Su; Zachary M Callahan; Kristine Kuchta; John G Linn; Stephen P Haggerty; Woody Denham; Michael B Ujiki
Journal:  J Am Coll Surg       Date:  2020-02-17       Impact factor: 6.113

8.  The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with "typical" symptoms.

Authors:  J H Peters; T R DeMeester; P Crookes; S Oberg; M de Vos Shoop; J A Hagen; C G Bremner
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

Review 9.  Acta from the EndoFLIP® Symposium.

Authors:  Silvana Perretta; Oliver McAnena; Abrie Botha; Leslie Nathanson; Lee Swanstrom; Nathaniel J Soper; Haruiro Inoue; Jeffrey Ponsky; Blair Jobe; Jacques Marescaux; Bernard Dallemagne
Journal:  Surg Innov       Date:  2013-12-30       Impact factor: 2.058

10.  Relative Roles of Deterministic and Stochastic Processes in Driving the Vertical Distribution of Bacterial Communities in a Permafrost Core from the Qinghai-Tibet Plateau, China.

Authors:  Weigang Hu; Qi Zhang; Tian Tian; Dingyao Li; Gang Cheng; Jing Mu; Qingbai Wu; Fujun Niu; James C Stegen; Lizhe An; Huyuan Feng
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.